Intracranial bailout stenting with the Acclino (Flex) Stent/NeuroSpeed Balloon Catheter after failed thrombectomy in acute ischemic stroke: a multicenter experience
Background and purposeTo report on the feasibility, safety, and outcome of acute intracranial stenting (ICS) with the Acclino (Flex) Stent and NeuroSpeed Balloon Catheter in cases of failed mechanical thrombectomy...
47
- 10.1136/neurintsurg-2018-014459
- Nov 10, 2018
- Journal of NeuroInterventional Surgery
10
- 10.4244/eijv10sta11
- Aug 1, 2014
- EuroIntervention
43
- 10.1016/s0002-9149(99)00767-5
- Feb 1, 2000
- The American Journal of Cardiology
96
- 10.1136/neurintsurg-2016-012529
- Aug 8, 2016
- Journal of NeuroInterventional Surgery
172
- 10.1161/strokeaha.108.533810
- Jan 29, 2009
- Stroke
276
- 10.1177/1747493017701147
- Mar 24, 2017
- International Journal of Stroke
163
- 10.1016/j.jcin.2018.05.036
- Jul 1, 2018
- JACC: Cardiovascular Interventions
236
- 10.1016/s0140-6736(12)60949-0
- Jun 27, 2012
- The Lancet
132
- 10.3389/fneur.2018.00308
- May 7, 2018
- Frontiers in Neurology
1751
- 10.1056/nejmoa1105335
- Sep 15, 2011
- New England Journal of Medicine
- Book Chapter
- 10.1007/978-3-030-85411-9_43-1
- Jan 1, 2023
Permanent Y-Stent Implantation as Bailout Strategy After Failed Mechanical Thrombectomy for Acute Embolic Occlusion of a Middle Cerebral Artery
- Research Article
3
- 10.3389/fneur.2023.1256365
- Nov 17, 2023
- Frontiers in Neurology
Mechanical thrombectomy (MT) has become the standard treatment for acute ischemic stroke (AIS) with large vessel occlusion (LVO). First-pass (FP) reperfusion of the occluded vessel and fewer passes with stent retrievers show improvement in functional outcomes in stroke patients, while higher numbers of passes are associated with higher complication rates and worse outcomes. Studies indicate that a larger size of the stent-retriever is associated with a higher rate of first-pass reperfusion and improved clinical outcomes. In this retrospective study, we investigated the clinical performance of a recently developed and one of the largest stent-retrievers available in the treatment of LVO (pRESET 6-50, phenox GmbH, Bochum). All consecutive patients with ischemic stroke due to proximal large vessel occlusion treated with MT using the pRESET 6-50 stent-retriever in two tertiary stroke centers between 09/2021 and 07/2022 were included in this study. The reperfusion rate after MT was quantified by the modified thrombolysis in cerebral infarction (mTICI) score, and functional neurological outcome was evaluated with the National Institutes of Health Stroke Scale (NIHSS) score and the major early neurological recovery (mENR) rate after 24 h. Successful FP reperfusion was defined as mTICI ≥ 2b. Successful and complete reperfusion were defined as mTICI ≥ 2b and mTICI ≥ 2c, respectively. In total, 98 patients (52 men and 46 women) with a median age of 75 (range 25-95 years) were included. A total of 70 (72%) patients presented with an occlusion of the middle cerebral artery (MCA) in the M1 segment, 6 (6%) patients with an occlusion of the M2 segment, 17 (17%) patients with an occlusion of the internal carotid artery (ICA), and 5 (5%) patients with an occlusion of the obstructed basilar artery (BA). Successful FP reperfusion was achieved in 58 patients (62%). Successful and complete reperfusion were achieved in 95 (97%) and 82 (83%) patients, respectively. The median National Institutes of Health Stroke Scale (NIHSS) in all treated patients improved from 17 to 7.5. Major early neurological recovery (mENR) was observed in 34 patients (35.1%). MT with the pRESET 6-50 stent-retriever achieves high successful first-pass and final reperfusion rates in patients with AIS and LVO. The results of this study support the thesis to use large-format stent-retriever in proximal vessel occlusion MT whenever feasible in order to improve high FP and final reperfusion rate, which are known predictors of good clinical outcome.
- Research Article
- 10.1007/s00062-025-01577-6
- Oct 13, 2025
- Clinical neuroradiology
Mechanical thrombectomy (MT) is standard care for acute large vessel occlusion (LVO), but it fails in 10-20% of cases, often due to underlying intracranial artery stenosis (ICAS). In such cases, rescue stenting (RS), with or without angioplasty, may improve recanalization, but its clinical benefit remains debated. The purpose of this study was to define predictors of clinical outcome in this patient population. We conducted aretrospective multicenter study including 115 patients with ICAS-related occlusion of the middle cerebral artery (MCA) treated with MT and RS across 27international stroke centers. Baseline, procedural, and post-procedural variables were analyzed. The outcome measure was the ordinal shift of the 90-day modified Rankin Scale (mRS) score. Stepwise multivariate regression and structural equation modeling (SEM) were used to identify outcome predictors and explore mediation pathways. Successful recanalization (modified Treatment in Cerebral Infarction (mTICI) score ≥ 2b) was achieved in 94.8% of patients, with 73.0% reaching mTICI2c‑3. SEM showed that baseline Alberta Stroke Program Early CT Score (ASPECTS), stenting with angioplasty and achieving mTICI2c‑3 were associated with improved functional outcome, mediated by higher post-procedural ASPECTS. Post-procedural ASPECTS influenced functional outcome both directly (estimate = -0.45, p < 0.001) and indirectly by reducing the occurrence of symptomatic intracranial hemorrhage (sICH) (estimate = -0.09, p = 0.004). This model explained 36.5% of the variance in 90-day mRS scores. In patients with acute ICAS-related MCA occlusion, stenting with angioplasty and achieving mTICI2c-3 recanalization are associated with improved clinical outcome. These benefits are mediated by better post-procedural ASPECTS and reduced sICH. Prospective studies are warranted to confirm these findings.
- Research Article
- 10.1097/jcma.0000000000001131
- Jul 8, 2024
- Journal of the Chinese Medical Association : JCMA
Percutaneous transluminal angioplasty and stenting for severe stenosis of the intracranial carotid artery and its branches: Comparison of the Wingspan stent vs the Credo stent.
- Research Article
11
- 10.1016/j.wneu.2022.07.001
- Jul 7, 2022
- World Neurosurgery
Balloon Angioplasty Combined with Tirofiban as a First-Line Rescue Treatment After Failed Mechanical Thrombectomy for Middle Cerebral Artery Occlusion with Underlying Atherosclerosis
- Research Article
1
- 10.3389/fneur.2023.1181295
- Jun 16, 2023
- Frontiers in Neurology
In this review article, we summarized the current advances in rescue management for reperfusion therapy of acute ischemic stroke from large vessel occlusion due to underlying intracranial atherosclerotic stenosis (ICAS). It is estimated that 24-47% of patients with acute vertebrobasilar artery occlusion have underlying ICAS and superimposed in situ thrombosis. These patients have been found to have longer procedure times, lower recanalization rates, higher rates of reocclusion and lower rates of favorable outcomes than patients with embolic occlusion. Here, we discuss the most recent literature regarding the use of glycoprotein IIb/IIIa inhibitors, angioplasty alone, or angioplasty with stenting for rescue therapy in the setting of failed recanalization or instant/imminent reocclusion during thrombectomy. We also present a case of rescue therapy post intravenous tPA and thrombectomy with intra-arterial tirofiban and balloon angioplasty followed by oral dual antiplatelet therapy in a patient with dominant vertebral artery occlusion due to ICAS. Based on the available literature data, we conclude that glycoprotein IIb/IIIa is a reasonably safe and effective rescue therapy for patients who have had a failed thrombectomy or have residual severe intracranial stenosis. Balloon angioplasty and/or stenting may be helpful as a rescue treatment for patients who have had a failed thrombectomy or are at risk of reocclusion. The effectiveness of immediate stenting for residual stenosis after successful thrombectomy is still uncertain. Rescue therapy does not appear to increase the risk of sICH. Randomized controlled trials are warranted to prove the efficacy of rescue therapy.
- Research Article
1
- 10.1007/s10143-023-02143-9
- Sep 8, 2023
- Neurosurgical Review
Dual-lumen angioplasty balloon microcatheters make it possible to perform percutaneous transluminal angioplasty (PTA), low-profile stent delivery, and intrastent dilation without the microcatheter exchange technique. This technique has shown many advantages in recent years. We reviewed the techniques and applications in different intracranial vascular diseases and summarized the outcomes and indications. Gateway dual-lumen angioplasty balloon was used for PTA and kept in situ. Stent was delivered and deployed via Gateway microcatheter. Intrastent balloon dilation was performed after stent deployment. We retrospectively reviewed the clinical and imaging data, surgical procedures, technique application, and follow-up outcomes of six patients treated from 2020 to 2023. Neurological function was assessed by the modified Rankin scale (mRS). A literature review was performed using PubMed. All seven patients (4 males, 3 females; mean age, 62.6 ± 6.9years) underwent percutaneous transluminal angioplasty and stent deployment using a balloon microcatheter. There was one middle cerebral artery (MCA) aneurysm with parent artery stenosis, two MCA dissections, and four intracranial atherosclerotic stenoses (ICASs). The mRS score was 0 in five patients and 1 in two patients. Cerebral dissection with stenosis is the best indication, and its application in stent-assisted aneurysm coiling is inappropriate. This technique is controversial in ICAS treatment.
- Research Article
- 10.1002/brb3.70798
- Sep 1, 2025
- Brain and behavior
Intracranial stenting with the Neuroform Atlas stent is an emerging treatment option for symptomatic intracranial atherosclerotic stenosis. Nevertheless, the efficacy and safety of the Neuroform Atlas stent as an option for intracranial stenting remain debatable. This study enrolled clinical data from 264 consecutive patients diagnosed with symptomatic intracranial atherosclerotic stenosis treated with intracranial stenting with the Neuroform Atlas stent between January 2020 and February 2023 to assess the efficacy and safety of the procedure. The stenosis rate of the target artery was assessed using digital subtraction angiography, and the outcome of patients was evaluated using the modified Rankin Scale (mRS). Among 264 patients, the mean stenosis rate of the target artery was 88.82% ± 6.35% before the procedure (T0), 47.99% ± 9.37% at the end of the procedure (T1), and 41.86% ± 7.30% at 6-month follow-up (T2). The stenosis rate was statistically significant between T0 and T1 (p = 0.00), between T0 and T2 (p = 0.00), and between T1 and T2 (p = 0.00). At 12 months postoperatively, 226 patients had a good outcome (mRS 0-2) without stroke recurrence attributed tothe target artery, and 32 patients had a good outcome but with stroke recurrence. There were three cases of ischemic stroke and two cases of hemorrhagic stroke related to the stenting process. No intraprocedural deaths were reported. Intracranial stenting with the Neuroform Atlas stent is a potentially safe and effective treatment for symptomatic intracranial atherosclerotic stenosis. It demonstrates a statistically significant difference in the caliber of the target artery before and after treatment as well as significantly improves the cerebral ischemic symptoms of patients.
- Discussion
- 10.1016/j.asjsur.2024.08.213
- Feb 1, 2025
- Asian Journal of Surgery
Innovative wire stripper technique for rescue balloon angioplasty after failed thrombectomy in acute ischemic stroke: A case report
- Research Article
5
- 10.1161/strokeaha.122.041096
- Nov 11, 2022
- Stroke
The CASSISS trial (China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis), recently published in JAMA, is the most recent of several randomized controlled trials that have failed to show a benefit of percutaneous angioplasty and stenting over medical therapy for the prevention of stroke due to intracranial atherosclerotic stenosis. Current practice guidelines recommended that percutaneous angioplasty and stenting should not be performed routinely as a treatment for stroke prevention in patients with intracranial atherosclerotic stenosis. The CASSISS trial reinforces those recommendations and will not change practice, but it may provide some important lessons for future trial design.
- Research Article
5
- 10.1016/j.wneu.2019.12.096
- Dec 24, 2019
- World Neurosurgery
Stenting of Mobile Calcified Emboli After Failed Thrombectomy in Acute Ischemic Stroke: Case Report and Literature Review
- Discussion
11
- 10.1161/strokeaha.118.020541
- Mar 16, 2018
- Stroke
See related article, p 958 Best currently available evidence for intracranial stenting (ICS) in intracranial atherosclerotic disease (ICAD) patients comes from secondary stroke prevention studies.1,2 However, these data do not allow any conclusion on the efficacy or safety of ICS in acute stroke patients. Chang et al3 present multicenter experiences with permanent ICS as rescue therapy after failed mechanical thrombectomy (MT) in patients with acute ischemic stroke in the carotid territory. In their study, MT failed in 148 of 591 (25%) patients with occlusions of the internal carotid artery or middle cerebral artery (M1). This rate exceeds the rate of poor recanalization of 8% to 18% as known from the large recent MT trials4–8 which at least in part might be explained by different incidence of ICAD in the trial populations. In their study, Chang et al3 observed significantly better outcomes after rescue ICS than after traditional management without increasing symptomatic intracranial hemorrhage rate or mortality (modified Rankin Scale score of 0–2; 39.6% versus 22.0%; P =0.031). The …
- Research Article
- 10.1161/str.51.suppl_1.tp10
- Feb 1, 2020
- Stroke
Background: Limited prospective data exists on the use of intra-arterial (IA) thrombolytics as rescue therapy(RT) after failed mechanical thrombectomy(MT) in acute ischemic stroke(AIS) patients with large vessel occlusions LVO). The aim of this study is to investigate the use of IA recombinant tissue plasminogen activator(IA-rtPA) as RT in the prospective STRATIS Registry. Methods: Data from the STRATIS Registry, a multicenter study of AIS patients treated with the Solitaire stent-retriever as the first choice therapy within 8 hours from symptoms onset, were analyzed. Clinical and angiographic outcomes were compared between patients treated with and without IA-rtPA. Both anterior and posterior circulation occlusions were included in this substudy. Results: Of the 938 STRATIS patients with IA-tPA use reported, 809 and 129 were in the no IA-rtPA(83.2%) and IA-rtPA(13.8%)groups, respectively. No difference was seen in baseline demographics. Site of occlusion was similar between the groups, with the majority occurring in the MCA(72.4% versus 73.6%, p=0.74). IV-rtPA was administered in 63.0% and 70.5% of no IA-rtPA and IA-rtPA patients(p=0.11). Median IA-rtPA dose was 4mg(IQR 2-12). Mean onset to arterial puncture time was shorter in the IA-rtPA group(200.2±104.6 versus 228.2±98.5 minutes, p=0.003); however, mean puncture to procedure end time was longer in the IA-rtPA group(78.7±43.1 versus 63.1±35.9 minutes). Mean number of passes (2.2±1.4 versus 1.8±1.2,p=0.001) and rate of distal embolization(67.8% versus 54.5%, p=0.007) was significantly higher in the IA-rtPA group. Core lab adjudicated substantial reperfusion (mTICI≥2b) was achieved in 88.4% and 84.7% of no IA-rtPA and IA-rtPA patients(p=0.16). No difference was observed in rates of symptomatic intracranial hemorrhage(sICH) (1.4% versus 1.6%,p=0.70), good functional outcome (mRS≥2, 57.3% versus 59.2%, p=0.86), or mortality (15.5% versus 13.3%,p=0.80) at 90-days. Conclusion: Use of IA-rtPA after failed thrombectomy was not associated with an increased risk of sICH or mortality in the STRATIS Registry. These results suggest that IA thrombolysis may be a safe option as rescue therapy in select patients.
- Research Article
54
- 10.1016/j.wneu.2019.08.192
- Sep 5, 2019
- World Neurosurgery
Rescue Intracranial Stenting After Failed Mechanical Thrombectomy for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
- Research Article
39
- 10.1161/circulationaha.110.948166
- Jun 14, 2010
- Circulation
A 42-year-old woman was referred to our institution with sudden onset of ataxia, facial paresis, horizontal gaze palsy, and progressive dysarthria. The patient worsened within a few minutes, with appearance of left hemiparesis. The National Institutes of Health Stroke Scale Score was 13. On computer tomography scan 2 hours after stroke onset, no brain stem lesion or intracranial bleeding was visible. Computed tomographic angiography revealed a mid basilar vessel occlusion, which suggested embolic basilar artery occlusion. A 4-vessel angiogram with a 5F diagnostic catheter confirmed the basilar artery occlusion and depicted more precisely the location of the thrombus (Figure 1A). Figure 1. A, Digital subtraction angiography after vertebral injection demonstrates a mid basilar vessel occlusion. B, The angiogram after placement of the stent from the left P1 segment (white arrow) into the basilar artery showed flow restoration of the basilar artery with a narrowing in the middle part of the vessel due to compression of the thrombus into the arterial wall (black arrows). C, …
- Research Article
20
- 10.1016/j.neurad.2018.05.004
- Jun 18, 2018
- Journal of Neuroradiology
Bail-out intracranial stenting with Solitaire AB device after unsuccessful thrombectomy in acute ischemic stroke of anterior circulation
- Research Article
10
- 10.1002/ana.26967
- May 16, 2024
- Annals of neurology
We aimed to evaluate the association between rescue therapy (RT) and functional outcomes compared to medical management (MM) in patients presenting after failed mechanical thrombectomy (MT). This cross-sectional study utilized prospectively collected and maintained data from the Society of Vascular and Interventional Neurology Registry, spanning from 2011 to 2021. The cohort comprised patients with large vessel occlusions (LVOs) with failed MT. The primary outcome was the shift in the degree of disability, as gauged by the modified Rankin Scale (mRS) at 90 days. Additional outcomes included functional independence (90-day mRS score of 0-2), symptomatic intracranial hemorrhage (sICH), and 90-day mortality. Of a total of 7,018 patients, 958 presented failed MT and were included in the analysis. The RT group comprised 407 (42.4%) patients, and the MM group consisted of 551 (57.5%) patients. After adjusting for confounders, the RT group showed a favorable shift in the overall 90-day mRS distribution (adjusted common odds ratio = 1.79, 95% confidence interval [CI] = 1.32-2.45, p < 0.001) and higher rates of functional independence (RT: 28.8% vs MM: 15.7%, adjusted odds ratio [aOR] = 1.93, 95% CI = 1.21-3.07, p = 0.005) compared to the MM group. RT also showed lower rates of sICH (RT: 3.8% vs MM: 9.1%, aOR = 0.52, 95% CI = 0.28-0.97, p = 0.039) and 90-day mortality (RT: 33.4% vs MM: 45.5%, aOR = 0.61, 95% CI = 0.42-0.89, p = 0.009). Our findings advocate for the utilization of RT as a potential treatment strategy for cases of LVO resistant to first-line MT techniques. Prospective studies are warranted to validate these observations and optimize the endovascular approach for failed MT patients. ANN NEUROL 2024;96:343-355.
- Abstract
- 10.1016/j.jvir.2021.03.488
- Apr 28, 2021
- Journal of Vascular and Interventional Radiology
No. 67 Spontaneous and assisted recanalization of hemodialysis access after prior failed thrombectomy and abandonment: the Lazarus phenomenon
- Research Article
- 10.1177/15910199251380408
- Sep 24, 2025
- Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
BackgroundGuide catheter (GC) placement, whether distal or proximal, may influence the efficacy and safety of mechanical thrombectomy (MT) for acute ischemic stroke (AIS) due to large vessel occlusion (LVO). However, definitions of placement and procedural strategies vary across studies, limiting clarity.MethodsWe systematically searched PubMed, Embase, Scopus, and Web of Science from inception to September 1, 2024. Comparative studies of adult patients with anterior circulation AIS-LVO undergoing MT that reported GC placement were included. Both balloon GCs (BGCs) and non-BGCs were eligible. Data were pooled using random-effects models in R. Outcomes included functional independence (modified Rankin Scale 0-2 at 90 days), successful reperfusion (modified thrombolysis in cerebral infarction ≥2b or expanded thrombolysis in cerebral infarction ≥2c), first-pass recanalization (FPR), mortality, puncture-to-recanalization (PTR) time, and complications. Subgroup analyses were performed by thrombectomy technique and catheter type.ResultsSeven retrospective studies comprising 2148 patients (1042 proximal, 1106 distal) were analyzed. Distal placement was associated with higher rates of functional independence (risk ratio (RR): 1.25, 95% confidence interval (CI): 1.10-1.42), successful reperfusion (RR: 1.13, 95% CI: 1.04-1.22), and FPR (RR: 1.35, 95% CI: 1.15-1.58), as well as lower 90-day mortality (RR: 0.52, 95% CI: 0.28-0.82). PTR time was shorter with distal placement (mean difference: -7.7 min, 95% CI: -10.8 to -4.6). No significant differences were observed for symptomatic intracranial hemorrhage (RR: 0.96, 95% CI: 0.55-1.65) or emboli to new territory (RR: 0.84, 95% CI: 0.28-2.52). Benefits were consistent across both BGCs and non-BGCs. Heterogeneity existed in outcome definitions and techniques, and publication bias could not be excluded.ConclusionsDistal GC placement is associated with improved reperfusion, efficiency, and functional outcomes in MT for anterior circulation AIS-LVO, without increased complications. Given the retrospective nature of included studies, anatomic confounding, and inconsistent outcome definitions, findings should be considered preliminary. Multicenter trials are needed to confirm whether catheter position independently predicts MT outcomes.
- Research Article
6
- 10.2459/jcm.0b013e32835852fa
- Jan 1, 2014
- Journal of Cardiovascular Medicine
The benefit of the routine application of aspiration thrombectomy in primary percutaneous coronary intervention (PPCI) is now well established. The optimal management of patients who have 'failed' thrombectomy, characterized by a large residual thrombus burden after repeated mechanical thrombectomy, however, is not known. We report a case of failed aspiration thrombectomy in a 55-year-old man who was admitted to our institution with chest pain non-ST-elevation myocardial infarction due to a huge nonocclusive thrombus in an aneurysmatic segment of the left anterior descending coronary artery. Aspiration thrombectomy did little to reduce thrombus load and so the patient was treated with unfractioned heparin infusion and warfarin. Repeat coronary angiography at 7 days revealed complete thrombus resolution with thrombolysis in myocardial infarction grade 3 anterograde flow.This case demonstrates the potential for appropriate anticoagulation therapy as a treatment option for the management of patients following failed thrombectomy in PPCI.
- Research Article
- 10.1136/jnis-2025-023078
- Apr 25, 2025
- Journal of neurointerventional surgery
Although mechanical thrombectomy (MT) is an effective treatment for large vessel occlusion (LVO) with a high successful recanalization rate, MT failure (MTF) occurs in 10-15% of cases and is associated with unfavorable outcomes. However, little is known about the clinical, technical, and radiological reasons for MTF. We investigated the technical factors associated with MTF. We conducted a retrospective analysis of consecutive patients with anterior LVO prospectively included in the ongoing observational multicenter ROSSETTI registry. Patients were categorized according to the success (≥mTICI 2b) or failure (<mTICI 2b) of the MT procedure. Baseline clinical and demographic characteristics, endovascular MT techniques, and angiographic and clinical outcomes were compared. Multivariate analysis for prediction of MTF was performed. We analyzed 4135 patients, including 325 patients (7.9%) with MTF. Patients in the MTF group had a significantly lower Alberta Stroke Program Early CT Score (ASPECTS) at baseline (8 (7-10) vs 9 (8-10)), longer time since last time seen well (279 min vs 262 min), increased MT procedure time (76 min vs 31 min), higher rate of complications (23% vs 4%), higher symptomatic intracerebral hemorrhage (21% vs 7.9%), higher 24 hour National Institutes of Health Stroke Scale score (19 vs 6), worse functional outcome at 3 months (modified Rankin Scale score 0-2, 15.6% vs 53%), and higher mortality (45% vs 20%). Four or more passes were an independent predictor of MTF (OR 3.46, 95% CI 2.58 to 4.63; P<0.001). None of the endovascular techniques demonstrated a higher likelihood of MTF. In this study, MTF in anterior circulation LVO was associated with a high complication rate and worse outcomes.
- Research Article
- 10.1161/str.55.suppl_1.158
- Feb 1, 2024
- Stroke
Background: Mechanical thrombectomy (MT) fails to achieve successful reperfusion in up to 20% of large vessel occlusions (LVOs). Rescue strategies (RS) have shown promise in multicenter studies and meta-analyses. We aimed to evaluate the association between RS with functional outcomes compared to medical management (MM) in patients who underwent failed MT. Methods: This is a cross-sectional study using prospectively collected data from the Society of Vascular and Interventional Neurology (SVIN) Registry from 2018 to 2021. We included all adult patients with anterior circulation LVOs who experienced a failed MT (mTICI 0-2a after multiple attempts to clot retrieval) at the 14 participating centers. The patients were divided into two groups: those who received RS (including balloon angioplasty alone, intracranial stenting with or without balloon angioplasty) and those who only received MM. The primary outcome was the shift in the degree of disability, as measured by the mRS at 90 days. Additional outcomes included functional independence (90-day mRS score of 0-2), sICH, and mortality at 90 days. Results: A total of 642 patients were included in the analysis. The RS group consisted of 294 (45.8%) patients, while the MM group comprised 348 (54.2%) patients. A mTICI score of 2b-3 was achieved in 242/293 (82.6%) patients in the RS group. After adjusting for confounders, the RS group showed a favorable shift in the overall 90-day mRS distribution (acOR=1.97, 95%CI 1.36-2.85, p =<0.001) and higher rates of functional independence (RS: 30.7% vs. MM: 12%, aOR=2.39, 95%CI 1.34-4.26, p =0.003) ( Figure ) compared to the MM group. RS also showed lower rates of sICH (RS: 2.7% vs. MM: 9%, aOR=0.32, 95%CI 0.14-0.71, p =0.005) and 90-day mortality (RS: 29.5% vs. MM: 49.7%, aOR=0.49, 95%CI 0.33-0.74, p =<0.001). Conclusion: Our findings support the use of RS as a potential alternative for stroke patients with failed MT. Further prospective studies are needed to validate these observations.
- Research Article
- 10.1161/str.55.suppl_1.tp205
- Feb 1, 2024
- Stroke
Background and Purpose: Large vessel occlusion secondary to intracranial atherosclerotic disease (ICAD-LVO) has an estimated prevalence of 10-30%. Registry-based reports from high volume centers indicate that about 4-7% of mechanical thrombectomy (MT) due to LVO are accompanied with intracranial rescue stenting in the US, yet the trend and utilization of rescue stenting in US is unknown. Methods: Analysis of US National Inpatient Sample of strokes with mechanical thrombectomy with or without concomitant intracranial stenting from October 1st, 2016, to December 31st, 2020, was performed. Patient- and hospital-level characteristics were analyzed. Outcomes included favorable disposition (discharged to home) and in-hospital mortality. Results: Among 68,975 of stroke MT with recorded NIHSS during the study period (51.1% women; mean age, 69.1 [SD, 14.6] years; mean NIHSS score of 15.1 [SD, 7.7]), 1,635 (2.3%) underwent concomitant intracranial stenting (44% women; mean age, 64.8 [SD, 13.7] years; mean NIHSS score of 13.8 [SD, 8.1]). Characteristics associated with intracranial stent utilization were male sex, history of diabetes, hypertension, or chronic kidney disease, absence of atrial fibrillation or CHF, and southern US region. Favorable outcome was achieved in 23.6% of MT with stenting versus 32.3% without stenting (P<0.001). In-hospital mortality occurred in 17.1% of MTs with stenting versus 10.5% without stenting (P<0.001). In multivariable analysis among MTs with concomitant intracranial stenting, favorable outcome was associated with lower presenting NIHSS (OR, 0.91 [95% CI, 0.87-0.95], P<0.001), and absence of DM (OR, 0.41 [95% CI, 0.20-0.85], P<0.01). In-hospital mortality was associated with male sex (OR, 3.08 [95% CI, 1.38-6.87], P=0.005) and concomitant IV lytic administration (OR, 2.45 [95% CI, 1.01-5.96], P=0.02). Conclusions: In US practice, less than 3/100 MT’s are performed with concomitant intracranial stenting which is well below the prevalence of failed thrombectomy rates due to underlying ICAD-LVO. Further studies are needed to improve outcomes in this subset of patients.
- Research Article
1
- 10.1177/1591019920920988
- Apr 27, 2020
- Interventional Neuroradiology
Bi-directional feedback mechanisms exist between the heart and brain, which have been implicated in heart failure. We postulate that aortic stenosis may alter cerebral haemodynamics and influence functional outcomes after endovascular thrombectomy for acute ischaemic stroke. We compared clinical characteristics, echocardiographic profile and outcomes in patients with or without aortic stenosis that underwent endovascular thrombectomy for large vessel occlusion acute ischaemic stroke. Consecutive acute ischaemic stroke patients with anterior and posterior circulation large vessel occlusion (internal carotid artery, middle cerebral artery and basilar artery) who underwent endovascular thrombectomy were studied. Patients were divided into those with significant aortic stenosis (aortic valve area <1.5 cm2) and without. Univariate and multivariate analyses were employed to compare and determine predictors of functional outcomes measured by modified Rankin scale at three months. We identified 26 (8.5%) patients with significant aortic stenosis. These patients were older (median age 76 (interquartile range 68-84) vs. 67 (interquartile range 56-75) years, p = 0.001), but similar in terms of medical comorbidities and echocardiographic profile. Rates of successful recanalisation (73.1% vs. 78.0%), symptomatic intracranial haemorrhage (7.7% and 7.9%) and mortality (11.5% vs. 12.6%) were similar. Significant aortic stenosis was independently associated with poorer functional outcome (modified Rankin scale >2) at three months (adjusted odds ratio 2.7, 95% confidence interval 1.1-7.5, p = 0.048), after adjusting for age, door-to-puncture times, stroke severity and rates of successful recanalisation. In acute ischaemic stroke patients managed with endovascular thrombectomy, significant aortic stenosis is associated with poor functional outcome despite comparable recanalisation rates. Larger cohort studies are needed to explore this relationship further.
- Conference Article
1
- 10.1136/neurintsurg-2022-snis.61
- Jul 1, 2022
<h3>Background</h3> Mechanical thrombectomy (MT) is the standard of care for acute ischemic stroke secondary to large vessel occlusion (LVO). MT success (MTS) is associated with a five times greater chance of achieving a favorable clinical outcome. Despite major advances in catheter and stent retriever (SR) technology, MT failure (MTF) still occurs in approximately 15% of cases. The purpose of this study is to investigate the patient and procedural characteristics that predict MTF. <h3>Methods</h3> This is a retrospective review of the prospectively collected, multi-center, multi-national Stroke Thrombectomy and Aneurysm Registry (STAR). Patients who underwent MT for anterior or posterior circulation LVO were included. Patients were categorized by MTS or MTF, defined as modified Thrombolysis in Cerebral Infarction (mTICI) 2b or greater and less than mTICI 2b, respectively. Patient demographics, pretreatment information, and treatment information were compared and then included in a univariate (UVA) and multivariate analysis (MVA) for prediction of MTF. <h3>Results</h3> A total of 8452 patients were included in the analysis, of whom 1301(15.4%) experienced MTF. Patients in the MTF group were older (73 vs 71 years, p=0.008) and had higher percentage of poor pre-morbid mRS (10.8% vs 8.4%, p=0.17). No significant differences were found between race, sex, pre stroke medical comorbidities or Alberta Stroke Program Early CT Score (ASPECTS). Onset to puncture was greater in the MTF group (442 vs. 411 min, p=0.006). There were more ICA occlusions (15.6% vs. 13.5%) and basilar occlusions (7.8% vs. 6.2%) in the MTF group and more M1 occlusions (42.2% vs 37.5%) in the MTS group (p<0.001). More patients underwent aspiration as the final technique in the MTS group (35.3% vs 32.9%). Number of passes (3 vs 2) and total procedure time (77.3 vs 46.1 min) were higher in the MTF group (p<0.001). More patients in the MTF group required IA thrombolytic (14.7% vs. 8.3%, p<0.001). More patients in the MTS group had rescue intracranial stenting (7.9% vs 4.8%). There were more complications (14.7% vs 6.2%) and more symptomatic ICH (9.9% vs 5.7%, p<0.001) in the MTF group. Favorable outcome at 90 days was greater in the MTS group (42.6% vs 18.3%, P<0.001). On UVA, age, poor pretreatment mRS, posterior circulation occlusion, final technique SR, increased number of passes, and increased procedure time were associated with increased odds of MTF, while M1-M2 occlusions and rescue intracranial stenting with decreased odds of MTF. These correlations remained significant on MVA for final technique SR, rescue intracranial stenting, number of passes, and procedure time. <h3>Conclusion</h3> In one of the largest studies to evaluate factors associated with failure MT in real world practice, we demonstrate that MTF is associated with significantly more complications and worse outcome. Final use of aspiration and rescue intracranial stenting may increase chances of recanalization. <h3>Disclosures</h3> <b>M. Webb:</b> None. <b>M. Essibayi:</b> None. <b>S. Al Kasab:</b> None. <b>I. Maier:</b> None. <b>M. Psychogios:</b> None. <b>A. Alawieh:</b> None. <b>S. Wolfe:</b> None. <b>A. Arthur:</b> None. <b>T. Dumont:</b> None. <b>P. Kan:</b> None. <b>J. Kim:</b> None. <b>R. De Leacy:</b> None. <b>J. Osbun:</b> None. <b>A. Rai:</b> None. <b>P. Jabbour:</b> None. <b>M. Park:</b> None. <b>R. Crosa:</b> None. <b>M. Levitt:</b> None. <b>A. Polifka:</b> None. <b>W. Casagrande:</b> None. <b>S. Yoshimura:</b> None. <b>C. Matouk:</b> None. <b>R. Williamson:</b> None. <b>B. Gory:</b> None. <b>M. Mokim:</b> None. <b>I. Fragata:</b> None. <b>D. Romano:</b> None. <b>S. Chowdry:</b> None. <b>M. Moss:</b> None. <b>D. Behme:</b> None. <b>K. Limaye:</b> None. <b>A. Spiotta:</b> None. <b>J. Mascitelli:</b> 2; C; Stryker.
- Research Article
- 10.1136/jnis-2025-023921
- Oct 31, 2025
- Journal of neurointerventional surgery
- Research Article
- 10.1136/jnis-2025-024193
- Oct 31, 2025
- Journal of neurointerventional surgery
- Research Article
- 10.1136/jnis-2025-024053
- Oct 30, 2025
- Journal of neurointerventional surgery
- Research Article
- 10.1136/jnis-2025-024237
- Oct 28, 2025
- Journal of neurointerventional surgery
- Research Article
- 10.1136/jnis-2025-024271
- Oct 24, 2025
- Journal of neurointerventional surgery
- Research Article
- 10.1136/jnis-2025-024390
- Oct 23, 2025
- Journal of neurointerventional surgery
- Research Article
- 10.1136/jnis-2025-024129
- Oct 23, 2025
- Journal of neurointerventional surgery
- Research Article
- 10.1136/jnis-2025-024288
- Oct 23, 2025
- Journal of neurointerventional surgery
- Research Article
- 10.1136/jnis-2025-024213
- Oct 23, 2025
- Journal of neurointerventional surgery
- Research Article
- 10.1136/jnis-2025-024209
- Oct 22, 2025
- Journal of neurointerventional surgery
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.